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Summary
Although Toll-like Receptors (TLRs) play amajor func-
tion in innate recognition of pathogens, their role in an-
tigen processing and presentation in vivo is poorly un-
derstood. Here we establish that Toxoplasma gondii
profilin, a TLR11 ligand present in the parasite, is an
immunodominant antigen in the CD4+ T cell response
to the pathogen. The immunogenicity of profilin was
entirely dependent on both TLR11 recognition and
signaling through the adaptor myeloid differentiation
factor 88 (MyD88). Selective responsiveness to this
parasite protein was regulated at the level of antigen
presentation by dendritic cells (DC) and required
both TLR signaling and major histocompatibility com-
plex (MHC)class II recognitionacting incis. Thesefind-
ings support a major influence of TLR recognition in
antigen presentation by DC in vivo and establish a
mechanismbywhich TLR ligand association regulates
the immunogenicity of microbial antigens.
Introduction
Toll-like receptors (TLRs) are a major class of pattern-
recognition receptors involved in ‘‘self’’ versus ‘‘nonself’’
discrimination that play a major role in the initiation of the
both innate and adaptive immunity to infectious agents
(Takeda and Akira, 2005; Iwasaki and Medzhitov, 2004).
To date, 12 different TLRs have been identified in mam-
mals that recognize a number of distinct and highly
conserved chemical structures (pathogen-associated
molecular patterns, PAMP) present on nucleic acids,
carbohydrates, lipids, and proteins of microbial agents
(Takeda et al., 2003; O’Neill, 2006). Upon recognition of
their ligands, TLRs transduce signals through two path-
ways involving distinct adaptor proteins containing Toll/
IL-1R (TIR) domains (O’Neill et al., 2003). One of these
adaptors, MyD88, is utilized by all of the known TLRs
except TLR3, which instead signals through the TIR
domain-containing adaptor inducing IFN-b (TRIF), also
known as TIR domain-containing adaptor molecule 1
(TICAM-1) (Yamamoto et al., 2002; Oshiumi et al., 2003;
Hoebe et al., 2003). TLR4, the receptor for LPS, is unique
in its capacity to signal through either of the two adaptors
(Yamamoto et al., 2003). The end product of TLR signal-
ing is the nuclear factor-kB (NF-kB)-dependent induc-
*Correspondence: fyarovinsky@niaid.nih.govtion of proinflammatory cytokines and costimulatory
molecules required for immune response initiation.
Dendritic cells (DC) are important mediators of TLR
interaction with microbial ligands (Iwasaki and Medzhi-
tov, 2004). These major sentinels of the immune system
transport foreign antigens from the periphery to lym-
phoid organs where they initiate T cell responses (Ban-
chereau and Steinman, 1998). In order to do so, DC
must first be activated through TLR encounter with
PAMP, resulting in the induction of inflammatory cyto-
kines as well as migration to secondary lymphoid organs
(Kaisho et al., 2001; Kaisho and Akira, 2001). Recent in
vitro data suggest that TLR ligand interaction in DC
also directly affects the process of antigen (Ag) presen-
tation itself (Blander and Medzhitov, 2004, 2006; West
et al., 2004). Thus, in the absence of MyD88 signaling
or specific TLR, DC show impaired uptake of bacteria
or LPS-coated beads and subsequent stimulation of
CD4+ T cells (Blander and Medzhitov, 2004). Neverthe-
less, these findings have been difficult to generalize to
other systems, and their possible relevance in regulat-
ing T cell activation in vivo has never been formally
addressed.
In the present study we have examined the role of TLR
recognition in governing the CD4+ T cell response to a
pathogen-derived protein from the protozoan parasite
Toxoplasma gondii. This molecule, T. gondii profilin,
was recently identified by us as a TLR11 ligand that
selectively activates DC belonging to the CD8a+ subset
for the production of Interleukin-12 (IL-12) and other
cytokines by means of an MyD88-dependent pathway
(Yarovinsky et al., 2005; Yarovinsky and Sher, 2006).
We demonstrate here that although previously charac-
terized as a minor component in the parasite, profilin is
an immunodominant protein in the CD4+ T cell response
to a soluble extract of the tachyzoite stage of the para-
site (STAg) as well as to live T. gondii infection. We fur-
ther show that the immunodominance of profilin de-
pends on TLR11 and MyD88 both in vivo and in vitro
and appears to result from the enhanced and selective
uptake of the protein by CD8a+ DC expressing this sig-
naling pathway. Taken together, our findings suggest
that physical association with TLR ligands can play
a major role in promoting CD4+ T cell responsiveness
to protein Ag and, in the case of pathogens, may be an
important factor determining the selective immunoge-
nicity of microbial components.
Results
CD4+ T Cells from Mice Immunized with
a Complex Parasite Extract Selectively
Recognize T. gondii Profilin
It has been previously established that CD4+ T lympho-
cytes are rapidly activated in response to T. gondii infec-
tion and that they are necessary for host resistance to
the pathogen (Suzuki and Remington, 1988; Gazzinelli
et al., 1991; Araujo, 1991). We predicted that because
of its dual property as a protein Ag and TLR receptor ag-
onist that potently stimulates DC, T. gondii profilin might
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CD4+ T cell responses than other Ag in the parasite. To
test this hypothesis, we employed a previously estab-
lished protocol (Jankovic et al., 2002) mimicking T. gon-
dii infection in which mice are repeatedly immunized
with an unfractionated soluble extract of the tachyzoite
stage of the parasite (STAg) containing a complex mix-
ture of microbial components (Yarovinsky et al., 2005).
This procedure results in the induction of strong para-
site-specific CD4+ T cell response comparable to those
observed in infected animals (Jankovic et al., 2002). At 7
days after the last STAg injection, purified CD4+ T cells
from mice primed in this manner were assessed for their
recall proliferative responses to STAg versus recombi-
nant profilin via irradiated splenocytes from unimmu-
nized animals as antigen-presenting cells (APC). We
found that on a weight per weight basis, purified profilin
stimulated as much if not more proliferation than the
unfractionated parasite extract (Figure 1A) in recall as-
says, suggesting that although it is a minor component
in the pathogen (Yarovinsky et al., 2005), this protein is
a dominant Ag in the CD4+ T cell response elucidated
by T. gondii. Importantly, no measurable recall response
was observed to a second recombinant protein Cyclo-
philin-18, a parasite molecule previously identified in
STAg that functions as a CC chemokine receptor 5
(CCR5) rather than TLR ligand (Aliberti et al., 2003). Sim-
ilar results were obtained when IFN-g production was
measured as a read-out of CD4+ T cell reactivity (Fig-
ure 1B). The observed immunodominance of profilin
could not be explained by possible endotoxin contami-
nation of either the recombinant protein or STAg, since
the same response pattern was observed in STAg-
immunized TLR4-deficient mice (see Figure S1 in the
Supplemental Data available online).
The Immunogenicity of Profilin Depends
on Host TLR11 Expression
To determine whether the unusual CD4+ T cell stimula-
tory capacity of profilin stems from its property as a
TLR11 ligand, we compared recall responses to profilin
and STAg in parasite extract-immunized Tlr112/2 versus
WT mice, in each case using WT splenocytes as APC.
Strikingly, we found that profilin failed to elicit a substan-
tial recall response in the TLR11-deficient animals and
that in addition, the response to STAg was also greatly
diminished in these mice versus similarly immunized
WT mice (Figure 1C versus Figure 1A). Further analysis
revealed that CD4+ T cell activation as measured by
CD44 expression was substantially reduced in STAg-
immunized Tlr112/2 versus WT control animals (Fig-
ure 1D). The latter observation raised the possibility
that the nonresponsiveness of Tlr112/2 mice to profilin
stems from a generalized abrogation of APC cytokine
and costimulatory signals resulting from the absence
of the major TLR signal associated with the parasite
extract (Yarovinsky et al., 2005). To test this hypothesis,
we asked whether the inclusion of either LPS (Figure 1E)
or complete Freund’s adjuvant (data not shown) in the
STAg immunization protocol would rescue the profilin
response. We found that while addition of either of these
TLR stimuli corrected the defect in CD4+ T cell activation
in the immunized TLR11-deficient mice (Figure 1F), nei-
ther stimulus restored the dose-dependent CD4+ T cellrecall response to purified profilin (Figure 1E and data
not shown).
We next asked whether TLR11 governs the response
to profilin during natural infection with T. gondii. To do
so, WT and Tlr112/2 mice were inoculated with the
ME49 parasite strain, and 2 weeks postinfection, spleen
cells were restimulated with either STAg or recombinant
profilin, and IFN-g-producing CD4+ T cells were quanti-
tated by intracellular cytokine staining and flow cytome-
try. As shown in Figure 1G, infected WT mice mounted
strong recall responses to both STAg and profilin. Con-
sistent with the results obtained with STAg immuniza-
tion (Figure 1C), the response to profilin (as well as to
STAg itself) was found to be greatly diminished in the
infected Tlr112/2animals.
The Immunogenicity of T. gondii Profilin Depends
on Signaling through MyD88
To determine whether TLR11 governs the selective im-
munogenicity of profilin by simply promoting interaction
of the antigen with APC or whether immunogenicity of
profilin also requires signal transduction, we analyzed
the response of Myd882/2mice to either STAg or profilin
immunization. As shown in Figure 1H, STAg-immunized
Myd882/2 mice failed to mount a detectable recall re-
sponse to profilin and displayed a diminished response
to the parasite extract itself, findings that closely mir-
rored those obtained with Tlr112/2 mice (Figure 1C).
Taken together, the above data indicated that the
immunodominance of profilin depends on both its rec-
ognition by TLR11 and on the generation of an MyD88-
dependent signal.
The Immunogenicity of Profilin Depends on Dual
Expression of MyD88 and MHC Class II Molecules
in the Same Bone Marrow-Derived Cell Population
Although the CD4+ T cell response to profilin was greatly
impaired in MyD88-deficient mice, it was possible that
this defect is due to a generalized lack of TLR-induced
cytokine production in vivo (Takeda et al., 2003). To ad-
dress whether MyD88 expression is required within anti-
gen-presenting cells, bone marrow chimera experiments
were performed involving WT recipients reconstituted
with a 1:1 mixture of H2-Ab12/2 (MHC class II-deficient)
and Myd882/2 BM cells (Figure 2). As expected, chi-
meras reconstituted with WT or MHC class II-deficient
BM cells and injected with STAg produced high amounts
of serum IL-12 measured at 6 hr whereas the chimera re-
constituted with Myd882/2 BM failed to respond. Also
as expected, chimeras reconstituted with a mixture of
Myd882/2 and MHC class II-deficient BM cells mounted
a vigorous cytokine response (Figure 2A). CD4+ T cell re-
call responses to profilin were then analyzed by intracel-
lular IFN-g staining in the same animals after repeated
immunization with STAg as described above. As indi-
cated in Figures 2B and 2C, the mixed chimeras reconsti-
tuted with both Myd882/2 and MHC class II-deficient
BM displayed greatly diminished CD4+ T cell IFN-g re-
sponses to STAg or profilin in comparison with the con-
trol WT into WT chimeras despite their unimpaired IL-12
production (Figure 2A). This reduction in IFN-g+CD4+ T
cells was not due to their conversion into an IL-4-positive
(Th2) population (Figures 2B and 2C). Similar results were
obtained when proliferative responses were assayed in
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657Figure 1. Dominant CD4+ T Cell Response to Profilin in T. gondii Ag-Primed WT but Not TLR11- or MyD88-Deficient Mice
(A) WT animals were immunized i.p. with 10 mg of STAg 5 times at 4 day intervals and spleens harvested on day 7 after the last injection. CD4+
T cells were then sort-purified and restimulated in the presence of irradiated WT splenocytes as APC with increasing doses of STAg (filled
circles), profilin (open circles), or a control parasite protein cyclophilin-18 (open triangles). Proliferation of T cells was then measured by incor-
poration of H3-thymidine.
(B) IFN-g production measured by ELISA in supernatants of the same cultures restimulated with either STAg (black bars), profilin (open bars), or
cyclophilin-18 (gray bars) at the 10 mg/ml dose level.
(C) Tlr112/2 mice were immunized with STAg as in (A) and proliferative recall responses to either STAg (filled circles) or profilin (open circles)
assayed as above.
(D) Spleen cells from the same naive and immunized mice shown in (A) and (C) were stained for both CD4 and CD44. The histograms show CD44
staining gated on CD4+ T cells from naive WT mice (shadow), WT mice immunized with STAg (bold line), and Tlr112/2mice immunized with STAg
(thin line).
(E) Tlr112/2 animals were immunized as described above with STAg but in this case with the inclusion of LPS (10 mg/mouse). Recall responses
were measured against STAg (filled circles) or profilin (open circles) also as above.
(F) CD44 staining gated on CD4+ T cells from naive WT mice (shadow), WT mice immunized with STAg+LPS (bold line), or Tlr112/2 mice immu-
nized with STAg+LPS (thin line).
(G) WT and Tlr112/2mice were infected i.p. with 20 cysts of the Me49 T. gondii strain. 14 days later, spleen cells from these animals were restimu-
lated in vitro with 10 mg/ml of either STAg or profilin and IFN-g-secreting CD4+ T cells quantitated in the cultures by intracellular staining.
(H) WT (circles) or Myd882/2 (triangles) animals were repeatedly immunized with STAg, and CD4+ T cell responses to either STAg (filled symbols)
or profilin (open symbols) were analyzed by the protocol described above. The experiments shown are representative of 3–5 performed, each
involving pooled spleens from at least three mice per group. The proliferation values are means 6 standard deviation (SD) of H3-thymidine
incorporation counts from duplicate or triplicate cultures.the same cultures (data not shown). The above observa-
tions argued that the unusual immunogenicity of profilin
depends on the dual expression of MyD88 and MHCclass II on the same BM-derived cell population and is
not simply the result of the potent systemic TLR-depen-
dent cytokine response triggered by the protein.
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658Figure 2. In Vivo Response to Profilin Requires Dual Expression of MyD88 and MHC Class II in the Same BM-Derived Cell Population
Irradiated C57BL/6 mice were reconstituted with BM cells from WT, Myd882/2, H2-Ab12/2, or a 1:1 mixture of the latter two cell populations.
8 weeks later, the animals were repeatedly immunized with STAg as in previous experiments.
(A) Serum IL-12p40 levels measured by ELISA 6 hr after the first STAg injection. Nonchimeric WT, TLR11-, and MyD88-deficient mice receiving
the same treatment are shown as controls. Data shown are mean 6 SD of determinations on five animals per group.
(B and C) Recall response to STAg (B) or profilin (C) assayed in the above animals at day 7 after the last immunization. The response was quan-
tified by intracellular cytokine staining for IFN-g and IL-4 on day 3 poststimulation to assess whether changes in Th1 cytokine levels were
reflected in enhanced Th2 activity. The results shown are representative of repeat experiments both performed with two independently derived
sets of chimeras.Antigen Presentation of Profilin by DC Is MyD88
Dependent and Limited to the CD8a+ Subset
To characterize the MyD88-dependent cell population
required for the immunogenicity of profilin, ex vivo ex-
periments were performed in which splenic APC from
STAg-injected mice were used to stimulate a pool of dif-
ferent profilin-specific CD4+ T cell clones. Initial experi-
ments (data not shown) indicated that only the CD11c+
spleen cell fraction was able to trigger proliferation of
these T lymphocytes. Interestingly, in kinetic experi-
ments, peak antigen presentation by the CD11c+ popu-
lation was observed at 6 hr postinjection (Figure 3A), a
time corresponding to that previously described as the
period of maximal IL-12 production by DC after STAg
injection (Reis e Sousa et al., 1997; Schulz et al., 2000).
Similarly, as reported previously for DC IL-12 produc-
tion, the antigen-presentation function of DC primed
in vivo by STAg was restricted to the CD8a+ subset (Fig-
ures 3B and 3C). Despite their similar requirements,
STAg-induced IL-12 production and profilin-specific
antigen presentation were shown to be independent
functions since DC from IL-12p40-deficient mice
showed unimpaired APC function in our assay (Figures
3D and 3E). Importantly, DC stimulation of profilin-spe-
cific CD4+ T cells in common with in vivo responsiveness
to the same antigen was strictly dependent on both
MyD88 and TLR11 (Figures 3F and 3G), arguing that
TLR regulation of this response occurs primarily at the
level of CD8a+ DC.
To determine whether the combined TLR11 and
MyD88 requirement for profilin presentation is due
merely to a necessity for DC maturation or migration,
we attempted to rescue the response by coinjecting
MyD88-deficient animals with LPS in addition to STAg.
Consistent with previous findings, the inclusion of LPS
resulted in both the migration and recruitment of splenicDC presumably through the MyD88-independent TRIF
pathway (Kaisho and Akira, 2001; Kaisho et al., 2001;
and data not shown). Nevertheless, the DC from these
coinjected animals failed to stimulate profilin-specific
CD4+ T cells, arguing that the requirement for TLR11 in
antigen presentation occurs at the level of DC recogni-
tion of the protein and is not due solely to its function
in DC activation (Figure S2).
The requirements for TLR11 and MyD88 in presenta-
tion of profilin to CD4+ T cells were also evident when
mice were infected with live tachyzoites (the rapidly
growing stage of the T. gondii parasite). While CD8a+
splenic DC recovered from WT mice 6 hr after parasite
inoculation potently stimulated proliferation of profilin-
specific CD4+ T cells, DC from similarly infected
MyD88- or TLR-deficient animals were highly defective
in promoting this response (Figure S3)
The Role of MyD88 in Profilin-Induced CD4+
T Cell Responses Is DC Intrinsic
To further address the role of MyD88 signaling in the
stimulation of CD4+ T cell responses by profilin-primed
DC, we asked whether this requirement is intrinsic to
the APC itself or depends on the expression of the adap-
tor molecule in unrelated cells in the host environment.
To do so, we prepared mixed chimeric animals in which
WT mice were reconstituted with a 1:1 ratio of WT and
MyD88-deficient BM cells expressing either CD45.1 or
CD45.2, respectively. These, as well as control chimeras,
were then injected with STAg and the spleens recovered
6 hr later and separated into CD11c+ populations of
Myd882/2 and WT origin by means of the presence of
the appropriate CD45 allelic markers (Figures 4A–4C).
The sorted DC populations were then tested for their
ability to stimulate profilin-specific CD4+ T cells. WT
(MyD88+ CD45.1+) DC isolated from mice reconstituted
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Myd882/2BM cells induced potent CD4+ T cell prolifera-
tion (Figure 4D). In contrast, Myd882/2 CD45.12 DCs
recovered from either the mixed chimera or a control chi-
mera reconstituted with MyD88-deficient BM cells alone
failed to stimulate significant CD4+ T cells responses
(Figure 4D). These results confirmed that the require-
ment for MyD88 in DC priming by profilin is cell intrinsic
Figure 3. Stimulation of Profilin-Specific CD4+ T Cells by In Vivo
Primed DC Is TLR11 and MyD88 Dependent and Limited to the
CD8a+ Subset
C57BL/6 mice (3 per group) were i.p. injected with 10 mg of STAg or
PBS (empty bars), and spleen cells were recovered and pooled from
these animals at 6 hr (gray bars), 24 hr (dark gray bars), and 48 hr
(black bars) after antigen inoculation.
(A–C) Bulk CD11c+ (A) as well as CD11c+CD8a+ (B) or CD11c+CD8a2
(C) DC were then purified from these samples and incubated with
a mixture of profilin-specific CD4+ T cell clones for 72 hr. T lympho-
cyte proliferation was then measured by H3-thymidine incorpora-
tion.
(D and E) The experiment shown is representative of three per-
formed CD8a+ (D) and CD8a2 (E) DC were sort-purified from WT
(black bars) or IL-12p40-deficient animals (white bars) 6 hr post
STAg inoculation and tested for their ability to stimulate profilin-
specific CD4+ T cells as above.
(F and G) CD8a+ (F) and CD8a2 (G) DC from WT (black bars), MyD88-
deficient animals (white bars), or Tlr112/2 (gray bars) were sort-
purified 6 hr post STAg inoculation and tested as above. The exper-
iments shown in (D)–(G) involved DC recovered and pooled from
three mice per group and are representative of at least two experi-
ments performed. The data shown are the mean 6 SD.and is not the result of indirect maturation signals depen-
dent on this adaptor molecule.
In Vitro Stimulation of Profilin-Specific CD4+
T Cells Is Partially Dependent on TLR11
and MyD88 Expression in DC
We next addressed whether the same requirement for
TLR signaling in activation of profilin-specific CD4+ T
cell responses that we observed in vivo also occurs
with isolated DC directly exposed to the protein in vitro
in the absence of other interacting cell populations. To
do so, we sort-purified splenic DC from naive WT,
Myd882/2, or Tlr112/2 mice and cocultured them with
profilin-specific T cells in the presence of increasing
concentrations of STAg or profilin. Proliferative re-
sponses were then measured 72 hr later. As expected,
both antigen preparations induced potent responses in
the cultures containing WT DC. In contrast, at most
doses tested, reduced proliferation was observed in cul-
tures containing Myd882/2 or Tlr112/2 DC (Figure S4).
Nevertheless, this dependency on both MyD88 and
TLR11 was overcome at high antigen concentration,
suggesting that while TLR signaling facilitates triggering
of profilin-specific CD4+ T cells, it is not a mandatory
requirement.
MyD88/TLR11 Regulates Uptake of Profilin
by DC In Vivo
The above data indicated that MyD88- and TLR11-
dependent presentation of profilin is dose dependent
and therefore may reflect a role of TLR in Ag uptake by
DC distinct from their function in DC maturation. This
hypothesis is also compatible with the more pro-
nounced affects of TLR11 signaling in regulating profilin
responses in vivo as opposed to in vitro, since Ag con-
centration is more limiting in the former situation. To as-
sess the role of enhanced Ag uptake as an explanation
of the data, we injected mice with fluorescent-labeled
profilin (Alexa 488-profilin) and examined its incorpora-
tion by both CD8a+ and CD8a2 CD11c+ DC and then
assessed the ability of Alexa 488+ versus Alexa 4882
DC to activate profilin-specific CD4+ T cells. The Alexa
488-profilin conjugate was confirmed to be fully active
in its ability to trigger TLR11-dependent cytokine pro-
duction (Figure S5). As shown in Figure 5A, uptake of
the labeled Ag was observed in WT CD8a+, but not in
CD8a2 DC. Moreover, in the former population, DC
from WT animals showed a greater than 5-fold increase
in Alexa 488+ cells compared with either MyD88- or
TLR11-deficient DC, with the latter displaying no sub-
stantial enhancement in fluorescence with respect to
cells from uninjected mice. Consistent with these obser-
vations, Alexa 488+CD8a+ DC from WT mice were the
most effective of any of the Alexa 488+ or Alexa 4882
DC populations tested in terms of their ability to stimu-
late profilin-specific CD4+ T cells (Figure 5B).
Fusion of Profilin or CpG with Ovalbumin Results
in Markedly Enhanced OVA-Specific CD4+
T Cell Priming
The results presented above demonstrated that TLR
recognition and MyD88-dependent signaling regulate
the CD4+ T cell response to T. gondii profilin. Neverthe-
less, most TLRs recognize chemical structures that are
Immunity
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(A–C) Irradiated C57BL/6.SJL (CD45.1+) mice were reconstituted with WT (CD45.1+) (A), Myd882/2 (CD45.12) (B), or a mixture of WT and MyD88-
deficient (C) BM cells. 8 weeks later, the animals were injected with STAg (10 mg) and CD11c+CD45.1+ (WT) and CD11c+CD45.12 (Myd882/2) were
sort-purified from spleens as shown in density plots.
(D) The different DC populations were then tested for their ability to stimulate profilin-specific CD4+ T cell proliferation. The populations studied
and their respective flow-cytometric profile were as follows: WT/WT reconstitution (gray bars, quadrant 1); Myd882/2/WT reconstitution
(white bars-panel, quadrant 2); WT+ Myd882/2/WT reconstitution (black bars, WT DC; hatched bars, MyD88-deficient DCs; quadrant 3 and
4, respectively). The data shown are the mean 6 SD, the results are representative of two independent chimera experiments performed,
each involving at least six animals per group of which spleens from three mice were pooled for cell separation.nonpeptidic and thus would not be expected to be di-
rectly associated with protein epitopes during antigen
processing and presentation. To test whether associa-
tion with nonprotein TLR ligands can regulate antigen
priming of CD4+ T cells, we compared the immunogenic-
ity of ovalbumin (OVA) alone, or OVA admixed with a
TLR9 agonist (immunostimulatory sequences, 1018 ISS)
with that of the same protein antigen chemically conju-
gated with ISS (Hemmi et al., 2000; Cho et al., 2000).
As expected, addition of 1018 ISS to OVA resulted in
a significant CD4+ T cell response to the protein as mea-
sured by proliferative recall response (Figure 6A). Impor-
tantly, immunization with the same amount of protein
directly conjugated to the ISS TLR9 ligand led to a dra-
matically increased CD4+ T cell response to the antigen,
and this enhancement (as well as that induced by admix-
ing of the ISS) was not observed when MyD88- or TLR9-
deficient mice were immunized in the same experiment
(Figure 6B). Moreover, no responses were detected
when a nonstimulatory ISS (1040 ISS) was substituted
for the immunostimulatory oligonucleotide in the proto-
col (Figure 6A). The above findings directly demonstrate
the enhancing effects of TLR ligand linkage to protein in
promoting CD4+ T cell priming.
To further test the hypothesis that physical associa-
tion of TLR ligands with protein Ag promotes CD4+ T
cell priming, we asked whether covalent association of
profilin to OVA would result in augmented OVA-specific
CD4+ T cell responses to the latter antigen as a conse-
quence of the TLR11 agonist activity of the parasite pro-
tein. To do so, we constructed a recombinant Profilin-
OVA fusion protein. Fusion with OVA did not impair the
TLR11-dependent IL-12-inducing activity of the profilin
molecule (Figure S5). Moreover, the profilin-OVA fusion
protein retained its profilin-specific immunogenicity in-
ducing CD4+ T cell responses at a level comparable to
that stimulated by an equivalent amount of unmodified
profilin or profilin admixed at a 1:1 ratio with OVA (Fig-
ure 6C). When tested for its ability to trigger OVA-spe-
cific T cell responses, the profilin OVA fusion profilin
was found to be highly immunogenic, inducing strongrecall proliferative responses not seen in mice injected
with either OVA alone or OVA admixed with profilin
(Figure 6D). Importantly, this enhanced immunogenicity
was dependent on TLR11 signaling (Figure 6D).
Taken together, the above findings demonstrated that
covalent association of TLR ligands with protein Ag
markedly enhances their induction of CD4+ T cell re-
sponses, thereby providing an explanation for the im-
munodominance of T. gondii profilin.
Discussion
The results presented here identify a function for TLR
signaling in regulating the immunogenicity of patho-
gen-associated protein antigens and elucidate a path-
way through which innate recognition can influence the
adaptive immune response. We observed that TLR11
recognition of T. gondii profilin renders this molecule
into a highly immunodominant Ag in the CD4+ T cell re-
sponse to the parasite, a property that appears to stem
from the enhanced uptake and presentation of the pro-
tein as a consequence of its activity as a TLR ligand.
Proteins generally are not targets for TLR recognition.
Bacterial flagellin and apicomplexan profilins are the
only well-defined examples of nonself proteins seen by
the TLR system (Hayashi et al., 2001; Yarovinsky et al.,
2005). Both molecules are also microbial antigens, and
previous studies with flagellin, which is recognized by
TLR5, have indicated that this protein is an immunodo-
minant Ag in the CD4+ T cell response to Salmonella
typhimurium (Cookson and Bevan, 1997; McSorley
et al., 2000), and large numbers of flagellin-specific
CD4+ T cells can be recovered from animals with chronic
intestinal inflammation presumably as a result of sensi-
tization by gut flora (Lodes et al., 2004). In the present
study, we observed that profilin, recognized by TLR11,
displays a similar immunodominance in the response
to T. gondii and formally demonstrated that this property
depends on TLR recognition and signaling at the level
of the same APC that is presenting the antigen. The
latter contention is based on the evidence that in
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WT,Myd882/2, or Tlr112/2mice (three per group) were injected i.p. with 10 mg of Alexa 488-profilin, and 6 hr later the animals were sacrificed and
spleens cells prepared and pooled for each group. The cells were then stained with CD11c-APC and CD8a-PE and analyzed for each of the latter
fluorochromes as well as Alexa 488.
(A) The results shown are histograms of Alexa 488 staining gated on either the CD8a+ (PE+) or CD8a2 (PE2) CD11c+ cell populations. The hor-
izontal bars indicate the percentage of Alexa 488+ cells for each analysis based on comparison with the background staining patter observed
with cells prepared from the uninjected WT animals.
(B) Ability of Alexa 4882CD8a+(fluorescence intensity < 103) and Alexa 488+CD8a+(fluorescence intensityR 103) cell populations identified in (A)
to stimulate profilin-specific CD4+ cells as described in previous figures. The experiment shown is representative of three performed.WT+Myd882/2 chimeric animals, only the WT DC are
able to activate profilin-specific CD4+ T cells and that
in MHC class II-deficient chimeras, priming of CD4+ T
lymphocytes with the same specificity depends on joint
expression of MyD88 and MHC class II in the same APC
compartment. Furthermore, nonspecific maturation sig-
nals delivered by a heterologous TLR ligand in them-
selves failed to render profilin into an immunogenic mol-
ecule. These data argue that the TLR11 signal delivered
by profilin influences its processing and presentation by
DC in a cis fashion within the same DC. We speculate
that this mechanism may also account for the previously
described immunodominance of the TLR5 ligand con-
taining protein flagellin.
A role for TLR signaling in the regulation of Ag pro-
cessing and presentation has been suggested in several
previous reports involving in vitro culture of DC with
TLR2 or TLR4 stimuli. In one of these studies, LPS stim-
ulation was shown to induce a rapid but transient en-
hancement of the uptake of FITC-labeled dextran bythese cells (West et al., 2004). More relevant to the
work presented here was the demonstration by Blander
and Medzhitov that MyD88-dependent TLR recognition
promotes the phagocytosis of Gram-negative or Gram-
positive bacteria (or particles covered with LPS or PGN,
respectively) while inducing phagosome maturation
(Blander and Medzhitov, 2004). In a subsequent study
(Blander and Medzhitov, 2006), it was shown that TLR
recognition regulates the ability of DC to present exper-
imental Ag to CD4+ T cells after phagocytosis of E. coli.
Our findings extend these earlier observations by dem-
onstrating that TLR signaling can directly promote the
ability of APC to take up and present soluble protein
Ag to CD4+ T cells in vivo and that this effect depends
on the physical association between the TLR ligand
and the protein in question.
Multiple mechanisms are likely to regulate CD4+ T cell
activation by profilin primed DC in vivo. Our studies
on DC interaction with profilin reveal that TLR11- and
MyD88-expressing DC have an enhanced capacity to
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662incorporate the protein when compared with DC lacking
these TLR components. We speculate based on these
results that TLR11, in addition to the promoting the
physical binding of this Ag to DC, may initiate MyD88-
dependent signals that regulate Ag internalization and/
or retention. Coupled together with TLR-dependent
triggering of DC maturation (Reis e Sousa et al., 1997;
Schulz et al., 2000; Yarovinsky et al., 2005), these effects
would lead to a major influence of the MyD88-depen-
dent TLR pathways on presentation of profilin or other
Ag that incorporate TLR ligands. It is important to
note, however, that the TLR requirement defined here
is not absolute and, as demonstrated in our in vitro ex-
periments, can be overcome at high Ag concentration.
Nevertheless, in the in vivo setting, where Ag levels are
in most cases limiting (Catron et al., 2004), the observed
role of TLR in Ag presentation of TLR ligand-associated
Ag should be pronounced, consistent with the findings
on profilin responses described above.
The concept that association with TLR ligands in-
creases protein immunogenicity is supported in the liter-
ature by several studies in which chemical coupling of
Figure 6. Covalent Association with ISS or Profilin Dramatically En-
hances the Induction of In Vivo CD4+ T Cell Responses by Ovalbu-
min via TLR/MyD88-Dependent Mechanism
(A and B) WT (A), Tlr92/2, and Myd882/2 (B) mice (2–3 per group)
were injected s.c. with 25 mg of either unmodified OVA protein
(open triangles), OVA, conjugated with 1018 ISS (filled circles),
OVA mixed with 1018 ISS (open circles), or OVA conjugated with
control oligonucleotides (filled triangles). 7 days later, CD4+ T cells
were sort-purified from pooled draining lymph nodes and restimu-
lated with titrated doses of OVA in the presence of irradiated WT
splenocytes as APC. CD4+ T cell proliferation was then measured
by incorporation of H3-thymidine as in previous figures.
(C) WT mice (3 per group) were immunized i.p. with 10 mg of either
unmodified OVA protein (open triangles), Profilin-OVA fusion protein
(filled circles), OVA mixed with profilin (1:1 ratio, open circles), or
profilin alone (filled triangles). Splenic CD4+ T cell responses to
titrated doses of profilin were then assayed as in (A) and (B) above.
(D) WT and Tlr112/2 mice were injected with either Profilin-OVA
fusion protein, OVA mixed with profilin, or OVA alone. CD4+ T cell re-
sponses to titrated doses of OVA fragment (311–348) containing the
OT-II CD4+ T epitope were then assayed as in (A)–(C) above. In pre-
liminary studies, s.c. injection of CpG and i.p injection of profilin
were found to be the optimal routes for immunization. The experi-
ments shown are representative of three performed.either TLR9, TLR7, or TLR8 agonists to either vaccine
target or model Ag was shown to result in amplified
CD8+ or Th1 cell responses (Cho et al., 2000; Shirota
et al., 2001; Hayashi et al., 2003; Wille-Reece et al.,
2005). That this enhancement can operate at the level
of TLR-dependent Ag presentation to CD4+ T cells is
demonstrated by the data shown here in which conjuga-
tion of OVA with CpG or fused expression with profilin
was shown to result in a marked elevations in in vivo
CD4+ T cell responses to the protein that were regulated
in an MyD88-dependent fashion by TLR9 or TLR11, re-
spectively. Again, it is important to note that in both
instances, the observed increases in immunogenicity
were not seen when TLR ligand was admixed rather
than directly linked to this protein Ag. Although not for-
mally demonstrated here, we speculate that the latter
requirement reflects a role for TLR in Ag internalization
in addition to the stimulation of APC maturation as
suggested by our in vivo experiments with unmodified
profilin.
An important issue raised by the findings on profilin
immunogenicity presented here concerns the function
of TLR ligand association in determining the immunodo-
minance of specific CD4+ T cell responses against path-
ogens during infection. In addition to the example of
bacterial flagellin discussed above, other microbial Ag
may incorporate TLR ligands as part of their structure.
For instance, the lipid moieties of pathogen-derived li-
poproteins can serve as TLR2 agonists (Takeda et al.,
2003), and a number of different microbial lipoproteins
have been demonstrated to be highly immunogenic
(Ghielmetti et al., 2005). Further work is needed to deter-
mine whether these molecules represent immunodomi-
nant Ag in the response to the pathogens from which
they are derived and, if so, whether the observed immu-
nogenicity is TLR and MyD88 dependent. If indeed our
observations on the role of TLR signaling in the CD4+ T
cell response to T. gondii profilin can be further general-
ized to other TLR ligand-associated microbial Ag, this
mechanism may deserve consideration as an important
factor biasing the specificity of the T cell repertoire di-
rected against pathogens and as a strategy exploited
by either host or pathogen in promoting the outcome
of infection.
Experimental Procedures
Animals
C57BL/6 mice were obtained from Jackson Laboratories (Bar Har-
bor, ME). Myd882/2 and Tlr42/2 mice on a C57BL/6 background
were generously provided by Dr. S. Akira (Osaka University, Japan).
TLR11-deficient animals on a mixed C57BL/6x129 background were
kindly provided by Drs. S. Ghosh and D. Zhang (Yale University, New
Haven, CT). WT (Tlr11+/+ or Tlr11+/2) littermates from the same
breeding stock gave responses to T. gondii profilin and STAg that
were indistinguishable from those of C57BL/6 mice in the major
experiments shown. C57BL/6.SJL (CD45.1+), H2-Ab12/2, and IL-
12p40-deficient mice were obtained from the National Institute of
Allergy and Infectious Diseases (NIAID) Animal Supply Contract at
Taconic Farms (Germantown, NY). All animals were maintained at
an American Association of Laboratory Animal Care-accredited
NIAID animal facility, and 8- to 12-week-old female mice were em-
ployed in all experiments. To generate bone marrow chimeric ani-
mals, mice were exposed to 950 RADs in a GammaCell 40 cesium
irradiator and reconstituted on the same day with 13 106 bone mar-
row cells from the donor mouse strain(s). The animals were then
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663maintained on acidified water for 4 wk and used in experiments 2–4
weeks later.
Parasite Antigens and Immunological Reagents
STAg (soluble tachyzoite antigen) was prepared from tissue-culture-
derived tachyzoites of the RH88 strain as previously described (Reis
e Sousa et al., 1997). Recombinant T. gondii profilin was generated
and purified as outlined previously (Yarovinsky et al., 2005). Ovalbu-
min fraction VI (Sigma, cat #A2512) and LPS 0111:B4 (Sigma, cat # L-
3024) were purchased from Sigma (St. Louis, MO). 1018 ISS and
1040 ISS were synthesized and conjugated with OVA by a coupling
procedure described elsewhere (Cho et al., 2000). OVA-profilin fu-
sion protein was generated by inserting the OVA311-348 fragment
(containing the OT-II CD4+ T cell epitope) in-frame with profilin via
an XhoI restriction site located at the N terminus of the profilin
gene and cloning the resulting construct into pET-14b vector (Nova-
gen). The recombinant Profilin-OVA fusion was then expressed in
BL21DE3pLys E. coli by the same protocol employed in the expres-
sion of the unmodified profilin gene. Alexa 488-labeled profilin was
prepared by reacting the purified protein with the fluorochrome
and purifying the product with a commercial kit from Invitrogen
(Carlsbad, CA). Flourescein isothiocyanate (FITC)-labeled CD8a,
CD11b, B220, and CD45.1 and phycoerythrin (PE)-labeled CD11c
monoclonal antibodies were purchased from BD Biosciences (San
Diego, CA).
In Vivo Immunization with Protein Antigens
To generate T. gondii-specific CD4+ T cell responses, WT or gene-
targeted mice were injected i.p. with STAg (10 mg per animal) 5 times
at 4 day intervals as previously described (Jankovic et al., 2002) and
utilized in experiments at 7–10 days after the last immunization. The
effect of profilin fusion with OVA was assessed by immunizing mice
by means of the same protocol with either OVA alone, OVA-profilin
fusion protein, or OVA mixed with profilin (1:1 weight ratio) at
a dose of 10 mg per injection. The effect of ISS (CpG oligonucleo-
tides) conjugation on OVA-specific CD4+ T cell responses was de-
termined by s.c. immunization with either OVA alone (25 mg), OVA
conjugated with 1018 ISS (1018-OVA, 25 mg), OVA conjugated with
control 1040 ISS (1040-OVA, 25 mg), or OVA (25 mg) admixed with
1018 ISS (25 mg) for each injection.
Toxoplasma gondii Infections
For studies of immune responses to live T. gondii infection, two dif-
ferent protocols were used. In the first, mice were inoculated i.p.
with an average of 20 tissue cysts of the avirulent Me49 strain pre-
pared from brain as described previously (Yarovinsky et al., 2005).
In the second procedure, mice were injected i.p. with 107 tachyzoites
(RH88 strain) from infected human fibroblast cultures.
Ex Vivo Measurement of Antigen-Specific
CD4+ T Cell Responses
To assay the response of animals immunized with the above antigen
preparations or infected with T. gondii, spleens (or in the case of ISS/
OVA-injected animals, inguinal lymph nodes) were harvested from
mice and pooled for each experimental group. The CD4+ popula-
tions were then purified by cell sorting (FACSVantage SE, BD Bio-
sciences), and aliquots (105 cells each) were then mixed at a 1:4 ratio
with irradiated WT splenocytes (as a source of APC) in 96-well U-
bottom plates. After addition of the indicated amounts of antigen,
the cultures were incubated for 48 hr and H3 thymidine (1 mCi) was
added to each well. Incorporation of the isotope was then deter-
mined after an additional overnight incubation. The data shown
are the means of duplicate or triplicate cultures.
Profilin-Specific CD4+ T Cells
Profilin-specific CD4+ T cells were generated from C57BL/6 mice im-
munized repeatedly with STAg (Jankovic et al., 2002) as in Figure 1.
In brief, FACS-purified CD4+ T lymphocytes restimulated with STAg
were cloned by limiting dilution and maintained in long-term culture
as previously described (Jankovic et al., 2000). Pools containing
equal numbers of five different profilin-specific CD4+ T cell clones
(identified by their response to the recombinant protein [Yarovinsky
et al., 2005]) were used to assess the ability of APC populations to
present profilin.Dendritic Cell Isolation
Dendritic cells were isolated from pooled (R3) spleens of naive mice
or animals injected 6 hr, 24 hr, or 48 hr previously with 10 mg of STAg
or 6 hr previously with live tachyzoites. For purification, single-cell
suspensions were incubated on ice for 15 min with either CD11c-
PE alone or a combination of CD11c and FITC-labeled CD8a-FITC
or CD45.1 antibodies. The cells were then washed and sorted on a
FACSVantage SE (BD Biosciences) as described previously (Yaro-
vinsky et al., 2005). In one set of experiments, the CD11c+CD8a+-
Alexa 488+ and CD11c+CD8a+Alexa 4882 cells were sort-purified
from animals injected 6 hr previously with 1 mg of Alexa 488-labeled
profilin alone (APC-labeled CD11c and PE-labeled CD8a antibodies
were used for staining in this procedure rather than FITC conjugates).
Assay of CD4+ T Cell Stimulatory Activity of DC
To measure the capacity of DC to activate profilin-specific CD4+ T
lymphocytes, the purified cell populations described above were
cocultured with profilin-specific CD4+ T cells at the ratios indicated
and proliferation measured H3 thymidine incorporation. In one set of
experiments CD8a+ DC from naive WT, Tlr112/2, or Myd882/2 mice
were used to stimulate profilin-specific CD4+ T cells in the presence
of different concentrations of exogenously added STAg or profilin.
Supplemental Data
Five Supplemental Figures can be found with this article online at
http://www.immunity.com/cgi/content/full/25/4/655/DC1/.
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